Marriott International Inc (MAR) stock
Close on Oct 30, 2026Market cap $104.12BP/E 41.4Yield 0.66%
Earnings
Marriott International's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Marriott International's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q3 FY2026ended Sep 30, 2026 | Nov 3, 2026Expected | – | – | – | – | – |
| Q2 FY2026ended Jun 30, 2026 | Aug 3, 2026before the open | – | – | $2.90 | $3.19 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 6, 2026before the open | $6.65B | +6.2% | $2.43 | $2.72 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 10, 2026before the open | – | – | $1.65 | $2.58 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 4, 2025before the open | $6.49B | +3.7% | $2.67 | $2.47 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 5, 2025before the open | $6.74B | +4.7% | $2.78 | $2.65 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 6, 2025before the open | $6.26B | +4.8% | $2.39 | $2.32 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 11, 2025before the open | $6.43B | +5.5% | $1.63 | $2.45 | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 4, 2024before the open | $6.26B | +5.5% | $2.07 | $2.26 | Release |
| Q2 FY2024ended Jun 30, 2024 | Jul 31, 2024before the open | $6.44B | +6.0% | $2.69 | $2.50 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 1, 2024before the open | $5.98B | +6.4% | $1.93 | $2.13 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 13, 2024before the open | $6.10B | +2.9% | $2.87 | $3.57 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 2, 2023before the open | $5.93B | +11.6% | $2.51 | $2.11 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 1, 2023before the open | $6.08B | +13.8% | $2.38 | $2.26 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 2, 2023before the open | $5.62B | +33.7% | $2.43 | $2.09 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 14, 2023before the open | $5.92B | +33.2% | $2.12 | $1.96 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 3, 2022before the open | $5.31B | +34.6% | $1.94 | $1.69 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 2, 2022before the open | $5.34B | – | $2.06 | $1.80 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 4, 2022before the open | $4.20B | – | $1.14 | $1.25 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 15, 2022before the open | $4.45B | – | $1.42 | $1.30 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 3, 2021before the open | $3.95B | – | $0.67 | $0.99 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 3, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 10, 2021before the open | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Feb 18, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Nov 6, 2020before the open | – | – | – | – | Filing |
| Q2 FY2020ended Jun 30, 2020 | Aug 10, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Marriott International's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Investment spending | FY2026 | $1.05B – $1.15B | – | New | May 6, 2026 |
| Net rooms growthnon-GAAP | FY2026 | +4.5% – +5% | – | New | May 6, 2026 |
Guidance vs results
The last range Marriott International gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q2 FY2026 | Adjusted EPS – diluted | $2.99 – $3.06 | $3.19 | Above range |
| FY2025 | Adjusted EPS – diluted | $9.85 – $10.08 | $10.02Σ4Q | Within range |
| Q3 FY2025 | Adjusted EPS – diluted | $2.31 – $2.39 | $2.47 | Above range |
| Q3 FY2025 | Revenue | $1.31B – $1.33B | $6.49B | Above range |
| Q2 FY2025 | Adjusted EPS – diluted | $2.57 – $2.62 | $2.65 | Above range |
| Q2 FY2025 | Revenue | $1.38B – $1.40B | $6.74B | Above range |
| Q4 FY2024 | Adjusted EPS – diluted | $2.31 – $2.39 | $2.45 | Above range |
| Q4 FY2024 | Revenue | $1.29B – $1.31B | $6.43B | Above range |
| Q3 FY2024 | Adjusted EPS – diluted | $2.27 – $2.33 | $2.26 | Below range |
| Q3 FY2024 | Revenue | $1.28B – $1.29B | $6.26B | Above range |
| Q2 FY2024 | Adjusted EPS – diluted | $2.43 – $2.48 | $2.50 | Above range |
| Q2 FY2024 | Revenue | $1.34B – $1.36B | $6.44B | Above range |
| Q4 FY2023 | Adjusted EPS – diluted | $2.04 – $2.13 | $3.57 | Above range |
| Q4 FY2023 | Revenue | $1.19B – $1.22B | $6.10B | Above range |
| Q3 FY2023 | Adjusted EPS – diluted | $2.00 – $2.09 | $2.11 | Above range |
| Q3 FY2023 | Revenue | $1.19B – $1.21B | $5.93B | Above range |
| Q2 FY2023 | Adjusted EPS – diluted | $2.09 – $2.15 | $2.26 | Above range |
| Q2 FY2023 | Revenue | $1.21B – $1.23B | $6.08B | Above range |
| Q1 FY2023 | Adjusted EPS – diluted | $1.82 – $1.88 | $2.09 | Above range |
| Q1 FY2023 | Revenue | $1.05B – $1.07B | $5.62B | Above range |
| Q4 FY2022 | Adjusted EPS – diluted | $1.77 – $1.84 | $1.96 | Above range |
| Q4 FY2022 | Revenue | $1.07B – $1.09B | $5.92B | Above range |
| Q3 FY2022 | Adjusted EPS - diluted | $1.59 – $1.69 | $1.69 | Within range |
| Q3 FY2022 | Revenue | $1.01B – $1.05B | $5.31B | Above range |
Guidance history
Every forecast Marriott International put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| May 6, 2026 | Investment spending | FY2026 | $1.05B – $1.15B | New |
| May 6, 2026 | Comparable systemwide constant $ RevPAR growth - Worldwide | Q2 FY2026 | +1.5% – +2.5% | New |
| May 6, 2026 | Adjusted EBITDA | Q2 FY2026 | $1.53B – $1.55B | New |
| May 6, 2026 | Adjusted EPS – diluted | Q2 FY2026 | $2.99 – $3.06 | New |
| May 6, 2026 | Net rooms growth | FY2026 | +4.5% – +5% | New |
| May 6, 2026 | Adjusted effective tax rate | Q2 FY2026 | 26.5% | New |
| May 6, 2026 | Owned, leased, and other revenue, net of owned, leased, and other expense | Q2 FY2026 | $60.00M | New |
| May 6, 2026 | General and administrative expenses | Q2 FY2026 | $220.00M – $230.00M | Raised |
| May 6, 2026 | Gross fee revenues | Q2 FY2026 | $1.54B – $1.55B | New |
| Aug 5, 2025 | Investment spending (including $355 million for citizenM) | FY2025 | $1.36B – $1.46B | New |
| Aug 5, 2025 | Comparable systemwide constant $ RevPAR growth Worldwide | FY2025 | +1.5% – +2.5% | New |
| Aug 5, 2025 | Adjusted EBITDA | Q3 FY2025 | $1.29B – $1.32B | New |
| Aug 5, 2025 | Adjusted EBITDA | FY2025 | $5.31B – $5.40B | New |
| Aug 5, 2025 | Adjusted EPS – diluted | FY2025 | $9.85 – $10.08 | New |
| Aug 5, 2025 | Adjusted EPS – diluted | Q3 FY2025 | $2.31 – $2.39 | New |
| Aug 5, 2025 | Capital return to shareholders | FY2025 | $4.00B | Raised |
| Aug 5, 2025 | Net rooms growth | FY2025 | +5% | New |
| Aug 5, 2025 | General, administrative, and other expenses | FY2025 | $965.00M – $985.00M | New |
| Aug 5, 2025 | General, administrative, and other expenses | Q3 FY2025 | $240.00M – $245.00M | New |
| Aug 5, 2025 | Owned, leased, and other revenue, net of direct expenses | FY2025 | $360.00M – $370.00M | Lowered |
| Aug 5, 2025 | Gross fee revenues | Q3 FY2025 | $1.31B – $1.33B | New |
| Aug 5, 2025 | Owned, leased, and other revenue, net of direct expenses | Q3 FY2025 | $80.00M – $90.00M | Lowered |
| Aug 5, 2025 | Gross fee revenues | FY2025 | $5.37B – $5.42B | New |
| May 6, 2025 | Investment spending (including $355 million for citizenM) | FY2025 | $1.36B – $1.46B | New |
| May 6, 2025 | Comparable systemwide constant $ RevPAR growth Worldwide | Q2 FY2025 | +1.5% – +2.5% | New |
| May 6, 2025 | Adjusted EBITDA | Q2 FY2025 | $1.37B – $1.39B | New |
| May 6, 2025 | Adjusted EPS – diluted | Q2 FY2025 | $2.57 – $2.62 | New |
| May 6, 2025 | Effective tax rate | Q2 FY2025 | 27% | New |
| May 6, 2025 | Owned, leased, and other revenue, net of direct expenses | Q2 FY2025 | $100.00M | New |
| May 6, 2025 | General, administrative, and other expenses | Q2 FY2025 | $240.00M – $245.00M | Raised |
| May 6, 2025 | Net rooms growth | FY2025 | +5% | New |
| May 6, 2025 | Capital return to shareholders | FY2025 | $4.00B | New |
| May 6, 2025 | Gross fee revenues | Q2 FY2025 | $1.38B – $1.40B | New |
| Nov 4, 2024 | Investment spending | FY2024 | $1.10B – $1.20B | Raised |
| Nov 4, 2024 | Comparable systemwide constant $ RevPAR growth Worldwide | Q4 FY2024 | +2% – +3% | New |
| Nov 4, 2024 | Adjusted EBITDA | Q4 FY2024 | $1.24B – $1.27B | New |
| Nov 4, 2024 | Adjusted EPS – diluted | Q4 FY2024 | $2.31 – $2.39 | New |
| Nov 4, 2024 | General, administrative, and other expenses | Q4 FY2024 | $275.00M – $265.00M | New |
| Nov 4, 2024 | Net rooms growth | FY2024 | +6.5% | Raised |
| Nov 4, 2024 | Capital return to shareholders | FY2024 | $4.40B | Raised |
| Nov 4, 2024 | Gross fee revenues | Q4 FY2024 | $1.29B – $1.31B | New |
| Nov 4, 2024 | Owned, leased, and other revenue, net of direct expenses | Q4 FY2024 | $95.00M | Lowered |
| Jul 31, 2024 | Investment spending | FY2024 | $1.00B – $1.20B | Reaffirmed |
| Jul 31, 2024 | Comparable systemwide constant $ RevPAR growth Worldwide | Q3 FY2024 | +3% – +4% | New |
| Jul 31, 2024 | Comparable systemwide constant $ RevPAR growth Worldwide | FY2024 | +3% – +4% | New |
| Jul 31, 2024 | Adjusted EBITDA | Q3 FY2024 | $1.23B – $1.25B | New |
| Jul 31, 2024 | Adjusted EBITDA | FY2024 | $4.95B – $5.02B | Lowered |
| Jul 31, 2024 | Adjusted EPS – diluted | Q3 FY2024 | $2.27 – $2.33 | New |
| Jul 31, 2024 | Adjusted EPS – diluted | FY2024 | $9.23 – $9.40 | Lowered |
| Jul 31, 2024 | Owned, leased, and other revenue, net of direct expenses | FY2024 | $345.00M – $350.00M | Lowered |
| Jul 31, 2024 | Owned, leased, and other revenue, net of direct expenses | Q3 FY2024 | $75.00M | New |
| Jul 31, 2024 | General, administrative, and other expenses | Q3 FY2024 | $240.00M – $250.00M | Raised |
| Jul 31, 2024 | Net rooms growth | FY2024 | +5.5% – +6% | Reaffirmed |
| Jul 31, 2024 | General, administrative, and other expenses | FY2024 | $1.02B – $1.03B | Raised |
| Jul 31, 2024 | Capital return to shareholders | FY2024 | $4.30B | Raised |
| Jul 31, 2024 | Gross fee revenues | Q3 FY2024 | $1.28B – $1.29B | New |
| Jul 31, 2024 | Gross fee revenues | FY2024 | $5.13B – $5.18B | Lowered |
| May 1, 2024 | Investment spending | FY2024 | $1.00B – $1.20B | New |
| May 1, 2024 | Comparable systemwide constant $ RevPAR growth Worldwide | Q2 FY2024 | +4% – +5% | New |
| May 1, 2024 | Comparable systemwide constant $ RevPAR growth Worldwide | FY2024 | +3% – +5% | New |
| May 1, 2024 | Adjusted EBITDA | Q2 FY2024 | $1.30B – $1.32B | New |
| May 1, 2024 | Adjusted EBITDA | FY2024 | $4.96B – $5.09B | New |
| May 1, 2024 | Adjusted EPS – diluted | Q2 FY2024 | $2.43 – $2.48 | New |
| May 1, 2024 | Adjusted EPS – diluted | FY2024 | $9.31 – $9.65 | New |
| May 1, 2024 | Owned, leased, and other revenue, net of direct expenses | Q2 FY2024 | $90.00M | New |
| May 1, 2024 | General, administrative, and other expenses | Q2 FY2024 | $253.00M – $258.00M | Raised |
| May 1, 2024 | Net rooms growth | FY2024 | +5.5% – +6% | New |
| May 1, 2024 | Owned, leased, and other revenue, net of direct expenses | FY2024 | $335.00M – $345.00M | New |
| May 1, 2024 | General, administrative, and other expenses | FY2024 | $1.02B – $1.04B | Raised |
| May 1, 2024 | Capital return to shareholders | FY2024 | $4.20B – $4.40B | Raised |
| May 1, 2024 | Gross fee revenues | Q2 FY2024 | $1.34B – $1.36B | New |
| May 1, 2024 | Gross fee revenues | FY2024 | $5.18B – $5.28B | New |
| Nov 2, 2023 | Investment Spending | FY2023 | $900.00M – $950.00M | Lowered |
| Nov 2, 2023 | Comparable systemwide constant $ RevPAR growth Worldwide | Q4 FY2023 | +6% – +7.5% | New |
| Nov 2, 2023 | Comparable systemwide constant $ RevPAR growth U.S. & Canada | Q4 FY2023 | +3% – +4% | Lowered |
| Nov 2, 2023 | Comparable systemwide constant $ RevPAR growth International | Q4 FY2023 | +14% – +16% | Raised |
| Nov 2, 2023 | Comparable systemwide constant $ RevPAR growth Worldwide | FY2023 | +14% – +15% | Lowered |
| Nov 2, 2023 | Comparable systemwide constant $ RevPAR growth U.S. & Canada | FY2023 | +8% – +9% | Lowered |
| Nov 2, 2023 | Comparable systemwide constant $ RevPAR growth International | FY2023 | +31% – +32% | Raised |
| Nov 2, 2023 | Adjusted EBITDA | Q4 FY2023 | $1.12B – $1.15B | New |
| Nov 2, 2023 | Adjusted EBITDA | FY2023 | $4.57B – $4.61B | Narrowed |
| Nov 2, 2023 | Adjusted EPS – diluted | Q4 FY2023 | $2.04 – $2.13 | New |
| Nov 2, 2023 | Adjusted EPS – diluted | FY2023 | $8.50 – $8.59 | Narrowed |
| Nov 2, 2023 | Owned, leased, and other revenue, net of direct expenses | Q4 FY2023 | $80.00M – $85.00M | New |
| Nov 2, 2023 | General, administrative, and other expenses | Q4 FY2023 | $255.00M | Raised |
| Nov 2, 2023 | Net Rooms Growth | FY2023 | +4.2% – +4.5% | Lowered |
| Nov 2, 2023 | Owned, leased, and other revenue, net of direct expenses | FY2023 | $328.00M – $333.00M | Lowered |
| Nov 2, 2023 | General, administrative, and other expenses | FY2023 | $935.00M | Raised |
| Nov 2, 2023 | Capital Return to Shareholders | FY2023 | $4.30B – $4.50B | Raised |
| Nov 2, 2023 | Gross fee revenues | Q4 FY2023 | $1.19B – $1.22B | New |
| Nov 2, 2023 | Gross fee revenues | FY2023 | $4.77B – $4.80B | Narrowed |
| Aug 1, 2023 | Investment Spending | FY2023 | $900.00M – $1.00B | Raised |
| Aug 1, 2023 | Comparable systemwide constant $ RevPAR growth Worldwide | Q3 FY2023 | +6% – +8% | New |
| Aug 1, 2023 | Comparable systemwide constant $ RevPAR growth U.S. & Canada | Q3 FY2023 | +2% – +4% | Lowered |
| Aug 1, 2023 | Comparable systemwide constant $ RevPAR growth International | Q3 FY2023 | +17% – +19% | Raised |
| Aug 1, 2023 | Comparable systemwide constant $ RevPAR growth Worldwide | FY2023 | +12% – +14% | Lowered |
| Aug 1, 2023 | Comparable systemwide constant $ RevPAR growth U.S. & Canada | FY2023 | +7% – +9% | Lowered |
| Aug 1, 2023 | Comparable systemwide constant $ RevPAR growth International | FY2023 | +28% – +30% | Raised |
| Aug 1, 2023 | Adjusted EBITDA | Q3 FY2023 | $1.11B – $1.14B | New |
| Aug 1, 2023 | Adjusted EBITDA | FY2023 | $4.54B – $4.65B | Raised |
| Aug 1, 2023 | Adjusted EPS – diluted | Q3 FY2023 | $2.00 – $2.09 | New |
| Aug 1, 2023 | Adjusted EPS – diluted | FY2023 | $8.36 – $8.65 | Raised |
| Aug 1, 2023 | Owned, leased, and other revenue, net of direct expenses | Q3 FY2023 | $65.00M | New |
| Aug 1, 2023 | General, administrative, and other expenses | Q3 FY2023 | $240.00M – $250.00M | Raised |
| Aug 1, 2023 | Net Rooms Growth | FY2023 | +6.4% – +6.7% | Raised |
| Aug 1, 2023 | Owned, leased, and other revenue, net of direct expenses | FY2023 | $330.00M – $335.00M | Lowered |
| Aug 1, 2023 | General, administrative, and other expenses | FY2023 | $915.00M – $935.00M | Raised |
| Aug 1, 2023 | Capital Return to Shareholders | FY2023 | $4.10B – $4.50B | Raised |
| Aug 1, 2023 | Gross fee revenues | Q3 FY2023 | $1.19B – $1.21B | New |
| Aug 1, 2023 | Gross fee revenues | FY2023 | $4.73B – $4.82B | Raised |
| May 2, 2023 | Investment Spending | FY2023 | $850.00M – $1.00B | New |
| May 2, 2023 | Comparable systemwide constant $ RevPAR growth Worldwide | Q2 FY2023 | +10% – +12% | New |
| May 2, 2023 | Comparable systemwide constant $ RevPAR growth U.S. & Canada | Q2 FY2023 | +5% – +7% | Lowered |
| May 2, 2023 | Comparable systemwide constant $ RevPAR growth International | Q2 FY2023 | +27% – +29% | Raised |
| May 2, 2023 | Comparable systemwide constant $ RevPAR growth Worldwide | FY2023 | +10% – +13% | New |
| May 2, 2023 | Comparable systemwide constant $ RevPAR growth U.S. & Canada | FY2023 | +6% – +9% | Lowered |
| May 2, 2023 | Comparable systemwide constant $ RevPAR growth International | FY2023 | +22% – +25% | Raised |
| May 2, 2023 | Adjusted EBITDA | Q2 FY2023 | $1.14B – $1.17B | New |
| May 2, 2023 | Adjusted EBITDA | FY2023 | $4.36B – $4.54B | Raised |
| May 2, 2023 | Adjusted EPS – diluted | Q2 FY2023 | $2.09 – $2.15 | New |
| May 2, 2023 | Adjusted EPS – diluted | FY2023 | $7.97 – $8.42 | Raised |
| May 2, 2023 | Owned, leased, and other revenue, net of direct expenses | Q2 FY2023 | $80.00M | New |
| May 2, 2023 | General, administrative, and other expenses | Q2 FY2023 | $245.00M – $250.00M | Raised |
| May 2, 2023 | Deletions | FY2023 | 1% – 1.5% | New |
| May 2, 2023 | Gross Rooms Growth | FY2023 | +5.5% | Raised |
| May 2, 2023 | Net rooms growth | FY2023 | +4% – +4.5% | Lowered |
| May 2, 2023 | Owned, leased, and other revenue, net of direct expenses | FY2023 | $300.00M – $310.00M | Lowered |
| May 2, 2023 | General, administrative, and other expenses | FY2023 | $915.00M – $935.00M | Raised |
| May 2, 2023 | Capital Return to Shareholders | FY2023 | $3.60B – $4.10B | Raised |
| May 2, 2023 | Gross fee revenues | Q2 FY2023 | $1.21B – $1.23B | New |
| May 2, 2023 | Gross fee revenues | FY2023 | $4.60B – $4.75B | Raised |
| Feb 14, 2023 | Comparable systemwide constant $ RevPAR growth Worldwide | Q1 FY2023 | +30% – +32% | New |
| Feb 14, 2023 | Comparable systemwide constant $ RevPAR growth U.S. & Canada | Q1 FY2023 | +25% – +27% | Lowered |
| Feb 14, 2023 | Comparable systemwide constant $ RevPAR growth International | Q1 FY2023 | +47% – +49% | Raised |
| Feb 14, 2023 | Comparable systemwide constant $ RevPAR growth Worldwide | FY2023 | +6% – +11% | New |
| Feb 14, 2023 | Comparable systemwide constant $ RevPAR growth U.S. & Canada | FY2023 | +5% – +9% | Lowered |
| Feb 14, 2023 | Comparable systemwide constant $ RevPAR growth International | FY2023 | +12% – +18% | Raised |
| Feb 14, 2023 | Adjusted EBITDA | Q1 FY2023 | $980.00M – $1.01B | New |
| Feb 14, 2023 | Adjusted EBITDA | FY2023 | $4.03B – $4.30B | New |
| Feb 14, 2023 | Adjusted EPS – diluted | Q1 FY2023 | $1.82 – $1.88 | New |
| Feb 14, 2023 | Adjusted EPS – diluted | FY2023 | $7.23 – $7.91 | New |
| Feb 14, 2023 | Owned, leased, and other revenue, net of direct expenses | Q1 FY2023 | $60.00M | New |
| Feb 14, 2023 | General, administrative, and other expenses | Q1 FY2023 | $200.00M – $205.00M | Raised |
| Feb 14, 2023 | Gross Rooms Growth | FY2023 | +5.5% | New |
| Feb 14, 2023 | Deletions | FY2023 | +1% – +1.5% | Lowered |
| Feb 14, 2023 | Net rooms growth | FY2023 | +4% – +4.5% | Raised |
| Feb 14, 2023 | Owned, leased, and other revenue, net of direct expenses | FY2023 | $265.00M – $285.00M | New |
| Feb 14, 2023 | General, administrative, and other expenses | FY2023 | $915.00M – $935.00M | Raised |
| Feb 14, 2023 | Gross fee revenues | Q1 FY2023 | $1.05B – $1.07B | New |
| Feb 14, 2023 | Gross fee revenues | FY2023 | $4.33B – $4.56B | New |
| Nov 3, 2022 | Investment spending | FY2022 | $500.00M | Lowered |
| Nov 3, 2022 | Comparable systemwide constant $ RevPAR Worldwide | Q4 FY2022 | +2% – +4% | New |
| Nov 3, 2022 | Comparable systemwide constant $ RevPAR Worldwide | FY2022 | -5% – -3% | New |
| Nov 3, 2022 | Adjusted EBITDA | Q4 FY2022 | $1.01B – $1.04B | New |
| Nov 3, 2022 | Adjusted EBITDA | FY2022 | $3.77B – $3.80B | Raised |
| Nov 3, 2022 | Adjusted EPS – diluted | Q4 FY2022 | $1.77 – $1.84 | New |
| Nov 3, 2022 | Adjusted EPS – diluted | FY2022 | $6.51 – $6.58 | Narrowed |
| Nov 3, 2022 | General, administrative, and other expenses | Q4 FY2022 | $225.00M – $235.00M | New |
| Nov 3, 2022 | Net rooms growth | FY2022 | +3% | Lowered |
| Nov 3, 2022 | General, administrative, and other expenses | FY2022 | $880.00M – $890.00M | New |
| Nov 3, 2022 | Gross fee revenues | Q4 FY2022 | $1.07B – $1.09B | New |
| Nov 3, 2022 | Owned, leased, and other revenue, net of direct expenses | Q4 FY2022 | $77.00M | Lowered |
| Nov 3, 2022 | Gross fee revenues | FY2022 | $4.02B – $4.04B | New |
| Nov 3, 2022 | Owned, leased, and other revenue, net of direct expenses | FY2022 | $269.00M | Lowered |
| Aug 2, 2022 | Investment spending | FY2022 | $600.00M – $650.00M | Lowered |
| Aug 2, 2022 | Adjusted EBITDA | Q3 FY2022 | $927.00M – $972.00M | New |
| Aug 2, 2022 | Adjusted EBITDA | FY2022 | $3.68B – $3.79B | New |
| Aug 2, 2022 | Adjusted EPS - diluted | Q3 FY2022 | $1.59 – $1.69 | New |
| Aug 2, 2022 | Adjusted EPS - diluted | FY2022 | $6.33 – $6.59 | New |
| Aug 2, 2022 | Gross fee revenues | Q3 FY2022 | $1.01B – $1.05B | New |
| Aug 2, 2022 | Gross fee revenues | FY2022 | $3.93B – $4.03B | New |
| May 4, 2022 | investment spending | FY2022 | $600.00M – $700.00M | Reaffirmed |
| May 4, 2022 | deletions | FY2022 | 1% – 1.5% | Reaffirmed |
| May 4, 2022 | gross rooms growth | FY2022 | +5% | Raised |
| May 4, 2022 | net rooms growth | FY2022 | +3.5% – +4% | Lowered |
| Feb 15, 2022 | investment spending | FY2022 | $600.00M – $700.00M | New |
| Feb 15, 2022 | deletions | FY2022 | 1% – 1.5% | New |
| Feb 15, 2022 | gross rooms growth | FY2022 | +5% | New |
| Feb 15, 2022 | net rooms growth | FY2022 | +3.5% – +4% | Lowered |
| Nov 3, 2021 | investment spending | FY2021 | $525.00M – $550.00M | New |
| Nov 3, 2021 | net rooms growth | FY2021 | +3.5% | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Marriott International filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Update
- Results
- Results
- Update
- Results
- Results
- Update
- Results
- Results
- Results
- Results
- Results